“Wait a long time” … “Pfizer” delivers shocking news to Americans



[ad_1]

The US newspaper “Washington Post” reported Tuesday that the pharmaceutical giant “Pfizer” has informed US officials that it cannot secure large quantities of the vaccine it is developing with Germany’s “Biontech” until next summer.

The newspaper added, citing sources familiar with the matter, that “this impossibility is due to the fact that other countries rushed to buy most of the quantities produced by the company, or those it intends to produce in the coming months.”

He said supplying massive additional quantities of the vaccine could be possible in late June or July 2021.

This means that the United States government may not be able to implement its strict program to vaccinate most Americans until late spring and early summer.

The United States is the country most affected by the epidemic in the world and, with more than 15 million people infected, it urgently needs the vaccine, which has been shown to be effective.

The United States had previously announced the purchase of 100 million doses of the American “Pfizer” vaccine and the German “Biontech” vaccine, in the hope that it would “help it intensify its efforts to contain the epidemic.”

Officials in the administration of President Donald Trump denied the existence of problems related to the supply of the vaccine in the second quarter of 2021, speaking of the presence of vaccines in development that may be added to the vaccine, “Pfizer” and “Biontech.”

However, others said that the problem with the availability of the vaccine is present.

[ad_2]